Carboplatin trials for Triple Negative Breast Cancer (TNBC)

All Carboplatin trials · All Triple Negative Breast Cancer (TNBC) trials

Phase breakdown

Recruiting trials studying Carboplatin for Triple Negative Breast Cancer (TNBC)

• A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)
  NCT07743190 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
  NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.
  NCT07394387 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

How many trials study Carboplatin for Triple Negative Breast Cancer (TNBC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.